Nanobiotix (France) Today
| NANO Stock | EUR 5.24 0.16 2.96% |
Performance0 of 100
| Odds Of DistressLess than 36
|
Nanobiotix is trading at 5.24 as of the 18th of April 2024, a -2.96 percent decrease since the beginning of the trading day. The stock's open price was 5.4. Nanobiotix has about a 36 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Nanobiotix SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 21st of October 2023 and ending today, the 18th of April 2024. Click here to learn more.
Nanobiotix SA, a late stage clinical company, develops and sells nanomedicine for the treatment of cancer worldwide. Nanobiotix SA was incorporated in 2003 and is headquartered in Paris, France. NANOBIOTIX operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. The company has 34.88 M outstanding shares. More on Nanobiotix SA
Moving together with Nanobiotix Stock
| 0.63 | VETO | Vetoquinol | PairCorr |
| 0.82 | BOI | Boiron SA | PairCorr |
| 0.85 | AB | AB Science SA | PairCorr |
Moving against Nanobiotix Stock
| 0.77 | HO | Thales SA | PairCorr |
| 0.47 | VIRP | Virbac SA | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Nanobiotix Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Nanobiotix's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Nanobiotix or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers - Major, Healthcare (View all Sectors) |
Nanobiotix SA (NANO) is traded on Euronext Paris in France and employs 103 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 115.07 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nanobiotix's market, we take the total number of its shares issued and multiply it by Nanobiotix's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Nanobiotix SA operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 34.88 M outstanding shares.
Nanobiotix SA has accumulated about 36.2 M in cash with (29.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.85.
Check Nanobiotix Probability Of Bankruptcy
Ownership AllocationNanobiotix SA maintains a total of 34.88 Million outstanding shares. Nanobiotix SA secures 3.78 % of its outstanding shares held by insiders and 25.56 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Nanobiotix Ownership Details
Nanobiotix Stock Price Odds Analysis
What are Nanobiotix's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Nanobiotix jumping above the current price in 90 days from now is under 95%. The Nanobiotix SA probability density function shows the probability of Nanobiotix stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Nanobiotix has a beta of 0.3045. This indicates as returns on the market go up, Nanobiotix average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Nanobiotix SA will be expected to be much smaller as well. Additionally, nanobiotix SA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Nanobiotix to move above the current price in 90 days from now is under 95 (This Nanobiotix SA probability density function shows the probability of Nanobiotix Stock to fall within a particular range of prices over 90 days) .
Nanobiotix SA Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Nanobiotix market risk premium is the additional return an investor will receive from holding Nanobiotix long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Nanobiotix. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Nanobiotix's alpha and beta are two of the key measurements used to evaluate Nanobiotix's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.85 | |||
| Standard Deviation | 2.51 | |||
| Variance | 6.28 | |||
| Risk Adjusted Performance | (0.10) |
Nanobiotix Stock Against Markets
Picking the right benchmark for Nanobiotix stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Nanobiotix stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Nanobiotix is critical whether you are bullish or bearish towards Nanobiotix SA at a given time. Please also check how Nanobiotix's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Nanobiotix without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
| All Next | Launch Module |
Nanobiotix Corporate Management
Elected by the shareholders, the Nanobiotix's board of directors comprises two types of representatives: Nanobiotix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nanobiotix. The board's role is to monitor Nanobiotix's management team and ensure that shareholders' interests are well served. Nanobiotix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nanobiotix's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sarah Gaubert | Head Department | Profile | |
| Elsa Borghi | Head Discovery | Profile | |
| Brandon Owens | VP Communication | Profile | |
| Earl Bergey | CoFounder | Profile | |
| Kathryn McNeil | VP Relations | Profile | |
| AnneJuliette MA | Chief Board | Profile | |
| Bart Rhijn | CFO Board | Profile |
How to buy Nanobiotix Stock?
Before investing in Nanobiotix, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Nanobiotix. To buy Nanobiotix stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Nanobiotix. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Nanobiotix stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Nanobiotix SA stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Nanobiotix SA stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Nanobiotix SA, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Nanobiotix SA?
The danger of trading Nanobiotix SA is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Nanobiotix is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Nanobiotix. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Nanobiotix SA is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanobiotix SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Nanobiotix Stock refer to our How to Trade Nanobiotix Stock guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Nanobiotix Stock analysis
When running Nanobiotix's price analysis, check to measure Nanobiotix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobiotix is operating at the current time. Most of Nanobiotix's value examination focuses on studying past and present price action to predict the probability of Nanobiotix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobiotix's price. Additionally, you may evaluate how the addition of Nanobiotix to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |